AMGN

Amgen Inc. News Headlines

$137.51
*  
3.82
2.86%
Get AMGN Alerts
*Delayed - data as of Oct. 20, 2014  -  Find a broker to begin trading AMGN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Amgen Sues Sanofi and Regeneron over PCSK9 Candidate - Analyst Blog
10/20/2014 5:10:00 PM - Zacks.com


Daily Dividend Report: HAL, VFC, ERF, AMGN, NEE, MOS, SJM, SEE
10/20/2014 2:43:19 PM - BNK Invest


Amgen Files Patent Infringement Suit Over Cholesterol Drug
10/17/2014 1:25:00 PM - Dow Jones Business News


Cramer: Regeneron's Head-to-Head Results 'Very Positive'
10/17/2014 11:46:00 AM - TheStreet


Amgen Files Patent Infringement Lawsuit Against Sanofi And Regeneron
10/17/2014 9:08:00 AM - RTT News


New Positive Clinical Data Supports Quest Towards Orphan Designations
10/17/2014 6:45:00 AM - Seeking Alpha


AbbVie Inc to Shire: It's Not You, It's My Country
10/16/2014 5:51:02 PM - Motley Fool


Biotech Stock Roundup: Gilead Nabs FDA Nod for Combo HCV Drug, Auxilium Accepts Endo Offer - Analyst Blog
10/15/2014 1:59:00 PM - Zacks.com


A Quick Look at Amgen, Inc.'s Drug Development Pipeline
10/15/2014 1:18:12 PM - Motley Fool


'Fast Money' Recap: Now May Be the Time to Buy Energy Stocks
10/15/2014 5:00:00 AM - TheStreet


Can Dividend Stock GlaxoSmithKline plc Bounce Back?
10/14/2014 1:09:05 PM - Motley Fool


Where Will Celgene Corporation Stock Be a Year From Now?
10/14/2014 12:20:02 PM - Motley Fool


3 Dividend Stocks to Buy If the Market Crashes
10/14/2014 9:14:02 AM - Motley Fool


Novartis Releases Data on Secukinumab for Plaque Psoriasis - Analyst Blog
10/13/2014 5:57:00 PM - Zacks.com


Amgen's Blinatumomab Gets Priority Review in the U.S. - Analyst Blog
10/13/2014 5:55:00 PM - Zacks.com


3 Companies With the Best Retirement Plans
10/12/2014 8:15:16 AM - Motley Fool


Nasdaq 100 Movers: NXPI, CTSH
10/10/2014 11:49:42 AM - BNK Invest


Amgen, Inc. Gives AbbVie Inc the Highest Form of Flattery
10/10/2014 8:50:02 AM - Motley Fool


Amgen's BiTE Immunotherapy Blinatumomab Gets FDA Priority Review Status
10/9/2014 4:19:00 PM - RTT News


Amgen Up on Positive Phase III Data on Psoriasis Biosimilar - Analyst Blog
10/9/2014 3:54:00 PM - Zacks.com


Portfolio Changes For The Third Quarter 2014
10/9/2014 9:14:00 AM - Seeking Alpha


Illumina Pads Gene Sequencing Lead With Pharma Deals
10/8/2014 4:04:00 PM - Investor's Business Daily


Amgen's Data on Evolocumab Published in The Lancet - Analyst Blog
10/8/2014 11:20:00 AM - Zacks.com


ETF Outlook: Health Care Select Sector SPDR ETF (XLV)
10/8/2014 9:26:45 AM - Marc Chaikin


Amgen'biosimilar Phase3 Plaque Psoriasis Study Met Primary Endpoint For Efficacy
10/8/2014 9:23:00 AM - RTT News